Atlas Trials

Volume Increase Versus Supplemental 4% Articaine Buccal Infiltration on Mepivacaine Inferior Alveolar Nerve Block Success

Clinical trial NCT05238727 · UNKNOWN

Trial details

NCT number
NCT05238727
Sponsor
Cairo University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Symptomatic Irreversible Pulpitis
Start date
2022-03-01
Primary completion
2023-03-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.